Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.13
-0.08 (-1.54%)
At close: Dec 19, 2025, 4:00 PM EST
5.12
-0.01 (-0.19%)
After-hours: Dec 19, 2025, 6:36 PM EST
Strata Critical Medical Market Cap
Strata Critical Medical has a market cap or net worth of $443.06 million as of December 19, 2025. Its market cap has increased by 32.18% in one year.
Market Cap
443.06M
Enterprise Value
370.61M
1-Year Change
32.18%
Ranking
Category
Stock Price
$5.13
Market Cap Chart
Since November 5, 2019, Strata Critical Medical's market cap has increased from $335.16M to $443.06M, an increase of 32.20%. That is a compound annual growth rate of 4.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 449.97M | 35.19% |
| Dec 31, 2024 | 332.83M | 26.33% |
| Dec 29, 2023 | 263.46M | 2.70% |
| Dec 30, 2022 | 256.52M | -58.82% |
| Dec 31, 2021 | 622.98M | 63.57% |
| Dec 31, 2020 | 380.88M | 12.72% |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |